Cargando…

A Rare Case of Primary Rectal Squamous Cell Carcinoma and the Use of Cytokeratin Markers

Lower gastrointestinal cancers are commonly adenocarcinoma of the colon and rectum and squamous cell carcinoma (SCC) of the anus. Rectal squamous cell carcinoma (SCC) is a rare gastrointestinal tract malignancy, as rectal SCC is assumed to be from the migration of anal squamous cells. However, prima...

Descripción completa

Detalles Bibliográficos
Autores principales: Iska, Sindu, Kumar, Kapisthalam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831453/
https://www.ncbi.nlm.nih.gov/pubmed/35165623
http://dx.doi.org/10.7759/cureus.21175
_version_ 1784648511358238720
author Iska, Sindu
Kumar, Kapisthalam
author_facet Iska, Sindu
Kumar, Kapisthalam
author_sort Iska, Sindu
collection PubMed
description Lower gastrointestinal cancers are commonly adenocarcinoma of the colon and rectum and squamous cell carcinoma (SCC) of the anus. Rectal squamous cell carcinoma (SCC) is a rare gastrointestinal tract malignancy, as rectal SCC is assumed to be from the migration of anal squamous cells. However, primary rectal SCC is rarer. Here, we present a case of a 63-year-old male who was found to have rectal SCC that was very close to the anus. Through literature review, it was noted that SCC and adenocarcinoma of rectal origin stain positive for cytokeratin CAM 5.2 and not the anal canal lesions. This patient's tumor was positive for CAM 5.2. The patient was treated with 5-fluorouracil and mitomycin C with radiation therapy for five weeks. The post-therapy repeat PET scan showed complete resolution of the tumor and oligometastasis. Unfortunately, the 20-week follow-up PET CT showed para-aortic and retrocrural lymph nodes consistent with malignancy. This case emphasizes the use of immunohistochemical stains for diagnosis and treatment planning in patients with rectal SCC. Once the diagnosis was confirmed, the patient was treated as anal SCC. The importance of differentiating between rectal and anal SCC can be argued, although the treatment is the same; however, the prognosis is worse based on nodal involvement in rectal SCC. Patients with early intervention have a five-year overall disease-free survival of greater than 80%.
format Online
Article
Text
id pubmed-8831453
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-88314532022-02-13 A Rare Case of Primary Rectal Squamous Cell Carcinoma and the Use of Cytokeratin Markers Iska, Sindu Kumar, Kapisthalam Cureus Internal Medicine Lower gastrointestinal cancers are commonly adenocarcinoma of the colon and rectum and squamous cell carcinoma (SCC) of the anus. Rectal squamous cell carcinoma (SCC) is a rare gastrointestinal tract malignancy, as rectal SCC is assumed to be from the migration of anal squamous cells. However, primary rectal SCC is rarer. Here, we present a case of a 63-year-old male who was found to have rectal SCC that was very close to the anus. Through literature review, it was noted that SCC and adenocarcinoma of rectal origin stain positive for cytokeratin CAM 5.2 and not the anal canal lesions. This patient's tumor was positive for CAM 5.2. The patient was treated with 5-fluorouracil and mitomycin C with radiation therapy for five weeks. The post-therapy repeat PET scan showed complete resolution of the tumor and oligometastasis. Unfortunately, the 20-week follow-up PET CT showed para-aortic and retrocrural lymph nodes consistent with malignancy. This case emphasizes the use of immunohistochemical stains for diagnosis and treatment planning in patients with rectal SCC. Once the diagnosis was confirmed, the patient was treated as anal SCC. The importance of differentiating between rectal and anal SCC can be argued, although the treatment is the same; however, the prognosis is worse based on nodal involvement in rectal SCC. Patients with early intervention have a five-year overall disease-free survival of greater than 80%. Cureus 2022-01-12 /pmc/articles/PMC8831453/ /pubmed/35165623 http://dx.doi.org/10.7759/cureus.21175 Text en Copyright © 2022, Iska et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Iska, Sindu
Kumar, Kapisthalam
A Rare Case of Primary Rectal Squamous Cell Carcinoma and the Use of Cytokeratin Markers
title A Rare Case of Primary Rectal Squamous Cell Carcinoma and the Use of Cytokeratin Markers
title_full A Rare Case of Primary Rectal Squamous Cell Carcinoma and the Use of Cytokeratin Markers
title_fullStr A Rare Case of Primary Rectal Squamous Cell Carcinoma and the Use of Cytokeratin Markers
title_full_unstemmed A Rare Case of Primary Rectal Squamous Cell Carcinoma and the Use of Cytokeratin Markers
title_short A Rare Case of Primary Rectal Squamous Cell Carcinoma and the Use of Cytokeratin Markers
title_sort rare case of primary rectal squamous cell carcinoma and the use of cytokeratin markers
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831453/
https://www.ncbi.nlm.nih.gov/pubmed/35165623
http://dx.doi.org/10.7759/cureus.21175
work_keys_str_mv AT iskasindu ararecaseofprimaryrectalsquamouscellcarcinomaandtheuseofcytokeratinmarkers
AT kumarkapisthalam ararecaseofprimaryrectalsquamouscellcarcinomaandtheuseofcytokeratinmarkers
AT iskasindu rarecaseofprimaryrectalsquamouscellcarcinomaandtheuseofcytokeratinmarkers
AT kumarkapisthalam rarecaseofprimaryrectalsquamouscellcarcinomaandtheuseofcytokeratinmarkers